Helicobacter Pylori
Copyright ©The Author(s) 2005.
World J Gastroenterol. Jul 28, 2005; 11(28): 4363-4366
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4363
Table 1 Primers of microsatellite markers
MarkersPrimersTm (°C)
BAT-265-FAM- TGACTACTTTTGACTTCAGCC58
5-AACCATTCAACATTTTTAACCC
D17S2615-HEX-AGGGATACTATTCAGCCCGAGGTG60
5-ACTGCCACTCCTTGCCCCATTC
D3S12835-TET-GGCAGTACCACCTGTAGAAATG60
5-GAGTAACAGAGGCATCGTGTATTC
D2S1235-FAM-AAACAGGATGCCTGCCTTTA60
5'-GGACTTTCCACCTATGGGAC
D3S16115-HEX-CCCCAAGGCTGCACTT60
5-AGCTGAGACTACAGGCATTTG
Table 2 H pylori infection in the normal, gastritis, intestinal metaplasia, and tumor samples
Tissue typeNumber of samplesInfection number of H pyloriInfection rates (%)
Normal3300
Gastritis453884.4
Intestinal metaplasia302376.7
Carcinoma463065.2
Table 3 MSI frequency according to H pylori status
MSI frequencyH pylori positive (30)H pylori negative (16)P1
MSI-H (12)36.7% (11/30)6.3% (1/16)0.035
MSI-L (3)6.7% (2/30)6.25 % (1/16)1.000
Table 4 P53 expression with regard to H pylori status in carcinomas
H pylori statusP53 positive (20)P
H pylori positive (30)170.0131
H pylori negative (16)3
Table 5 Length of representative fragments of five microsatellite loci in the normal tissue and peripheral blood sample of the gastric cancer patient
BAT-26D17S261
D3S1283
D2S123D3S1611
Peak no.1# (bp)2# (bp)3# (bp)4# (bp)5# (bp)6# (bp)7# (bp)
Normal119.15127.52133.78149.12147.25209.42262.76
Tumor120.30121.63131.45143.23147.36209.30262.85